Kingfisher study: Safety and efficacy of brolucizumab for DME
November 25th 2023The Kingfisher Study found that the visual outcomes after 1 year of brolucizumab, 6 mg, (Beovu, Novartis) in participants with diabetic macular edema (DME) did not differ significantly from those obtained with aflibercept
Read More
Polish researchers advocate for routine ophthalmologic exams in vasculitis cases
November 9th 2023The study underscores the potential benefits of early detection of pathological changes in the retina and choroid before ocular symptoms manifest, particularly highlighting the promise of choroidal vascularity index as a robust evaluation tool.
Read More
Clinical characteristics and progression of Geographic Atrophy in a Japanese population
November 7th 2023This retrospective, multicenter, observational study examined Japanese patients with GA to determine the clinical characteristics and GA progression rate associated with AMD in an Asian population.
Read More
AAO 2023: Phase 3 LYNX-1 trial: Phentolamine ophthalmic solution improves low-contrast night vision
November 2nd 2023Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution. The trial demonstrated substantial improvement in visual acuity on both evaluation days.
Read More
World Sight Day 2023: Focusing on preservation of vision in the workplace
October 11th 2023World Sight Day on October 12 highlights the vital role of eye care in workplaces. The International Agency for the Prevention of Blindness urges employers to prioritize eye health, aiming to enhance well-being, safety, and productivity.
Read More